Propiedad y actividad de insiders de Gossamer Bio, Inc. (GOSS): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $10.96 |
| Capitalización | $67M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-24 | Christian Waage | A-Award | 2,900,026 | $508K |
| 2026-08-24 | Peterson Caryn | A-Award | 5,800,051 | $1.0M |
| 2026-08-24 | Smith Robert Paul JR | A-Award | 5,800,051 | $1.0M |
| 2026-08-24 | Giraudo Bryan | A-Award | 5,800,051 | $1.0M |
| 2026-08-24 | Giraudo Bryan | A-Award | 25 | $0 |
| 2026-08-24 | Hasnain Faheem | A-Award | 5,800,051 | $1.0M |
| 2026-08-24 | Hasnain Faheem | A-Award | 166 | $0 |
| 2026-06-04 | Quisel John D | A-Award | 115,000 | $20K |
| 2026-06-04 | Drynan Skye | A-Award | 115,000 | $20K |
| 2026-06-04 | Daniel Thomas O | A-Award | 115,000 | $20K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $60000 | $315000 | $105.2M | $135.0M | $486.1M | $183.4M | $112.0M | $32.1M | $46.1M | $37.7M |
| Inversiones a Corto | 0 | 0 | $123.4M | $266.7M | $26.6M | $141.8M | $143.7M | $264.3M | $248.4M | $99.2M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $5.3M | $12.5M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $60000 | $445000 | $232.0M | $409.3M | $522.3M | $331.8M | $261.9M | $306.5M | $309.9M | $167.6M |
| Inmovilizado Material | 0 | 0 | $3.2M | $15.7M | $16.1M | $10.8M | $9.9M | $4.8M | $5.1M | $4.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $60000 | $445000 | $239.4M | $426.6M | $539.4M | $343.7M | $272.4M | $311.9M | $315.3M | $172.2M |
| Cuentas por Pagar | $40000 | $97000 | $2.2M | $956000 | $7.5M | $3.2M | $1.5M | $5.5M | $2.3M | $6.0M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $11.6M | $11.6M | 0 | 0 |
| Pasivos Corrientes | $143000 | $1.3M | $20.4M | $36.9M | $38.6M | $39.9M | $49.2M | $51.6M | $45.0M | $63.4M |
| Deuda a Largo | $40000 | $6.0M | 0 | $28.5M | $172.4M | $179.1M | $207.7M | $197.4M | $197.5M | $198.5M |
| Pasivos Totales | $183000 | $7.3M | $359.5M | $74.1M | $218.7M | $222.2M | $260.4M | $249.1M | $285.8M | $295.0M |
| Reservas | -$123000 | -$6.9M | -$153.9M | -$334.2M | -$577.5M | -$811.5M | -$1.03B | -$1.21B | -$1.27B | -$1.44B |
| Patrimonio Neto | -$123000 | -$6.9M | -$120.1M | $352.5M | $320.7M | $121.5M | $12.1M | $62.8M | $29.5M | -$122.8M |
| Deuda Total | $40000 | $6.0M | 0 | $39.5M | $183.7M | $185.2M | $225.7M | $212.5M | $202.9M | $202.9M |
| Deuda Neta | -$20000 | $5.7M | -$228.7M | -$362.2M | -$328.9M | -$140.0M | -$29.9M | -$84.0M | -$91.6M | $66.0M |
| Capital Circulante | -$83000 | -$821000 | $211.6M | $372.4M | $483.7M | $291.9M | $212.7M | $254.9M | $264.9M | $104.2M |
Salud financiera
| Deuda / Patrimonio | -0.42 |
| Ratio corriente | 0.53 |
Rentabilidad
| Rentabilidad sobre capital | 108.75% |
| Rentabilidad sobre capital invertido | 670.05% |
| Rentabilidad sobre activos | -162.91% |
| Margen bruto | 99.56% |
| Margen operativo | -311.70% |
| Margen neto | -235.00% |
Empresas relacionadas: CRVS · FDMT · KALV · LXRX · OLMA · PRTA · RAPT
Explorar sector: Healthcare · Biotechnology
Más secciones de GOSS: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones